Auxilium Pharmaceuticals Inc $20.02

down -0.30


31/7/2014 04:00 PM  |  NASDAQ : AUXL  
Industries : Drugs / Drug Related Products
Get Trend Analysis Icon Get AUXL Trend Analysis - it has underperformed the S&P 500 by 5%

Partner Headlines

  1. Salix Pharma Stock Falls Despite Tax-Inversion Deal

    IBD
  2. R.F. Lafferty Devalues Auxilium, QLT Deal

    Benzinga
  3. Benzinga's M&A Chatter for Thursday June 26, 2014

    Benzinga
  4. Auxilium swaps stock for QLT

    IBD
  5. Auxilium Acquiring QLT For New Products, Low Taxes

    IBD
  6. Aegis Capital Initiates Coverage On Auxilium Pharmaceuticals, Favors Acquisition

    Benzinga
  7. Morning Market Movers

    Benzinga
  8. Benzinga's Top #PreMarket Gainers

    Benzinga
  9. US Stock Futures Flat Ahead Of Jobless Claims, Consumer Spending Data

    Benzinga
  10. UPDATE: Auxilium Pharmaceuticals To Merge With Canadian Biotechnology Company ...

    Benzinga
  11. Market Wrap For June 11: Momentum Hit, Dow Suffers Triple Digit Loss

    Benzinga
  12. Mid-Afternoon Market Update: ULTA Salon Remains Steady After Strong Results; ...

    Benzinga
  13. Mid-Day Market Update: ULTA Salon Rises After Strong Results; Orexigen ...

    Benzinga
  14. Mid-Morning Market Update: Markets Drop; H&R Block Posts Higher Profit

    Benzinga
  15. Morning Market Losers

    Benzinga
  16. John Paulson's 4 Stocks Trading for Less Than He Paid for Them

    GuruFocus
  17. Auxilium Testim sales fall 76%

    IBD
  18. Earnings Scheduled For May 5, 2014

    Benzinga
  19. Mid-Day Market Update: Twitter Drops On Earnings; Pepco Shares Gain

    Benzinga
  20. Morning Market Losers

    Benzinga
  21. Benzinga's Top #PreMarket Losers

    Benzinga
  22. Auxilium Pharma to Present XIAFLEX Data at Urology Meeting

    Benzinga
  23. Biotech Auxilium Boosts Position In Men's Health Care

    IBD
  24. Benzinga's Top Downgrades

    Benzinga
  25. UPDATE: Morgan Stanley Downgrades Auxilium Pharmaceuticals as Growth May ...

    Benzinga
  26. US Stock Futures Edge Higher Ahead Of Jobless Claims, Factory Orders Data

    Benzinga
  27. Auxilium guidance cautious

    IBD
  28. Auxilium Q4 Beats Estimates, But Guidance Cautious

    IBD
  29. Benzinga's M&A Chatter for Wednesday January 29, 2014

    Benzinga
  30. Auxilium Pharmaceuticals Presents Interim Data on XIAFLEX for Retreatment ...

    Benzinga
  31. New ED Drug: Analysis of Vivus’s Prospects

    YCharts
  32. Auxilium Announces First Patient Dosed in Phase 2b Frozen Shoulder Syndrome ...

    Benzinga
  33. Auxilium gets nod from FDA

    IBD
  34. Mid-Afternoon Market Update: Markets Gain on Jobs Number; InterOil Falls ...

    Benzinga
  35. Auxilium Xiaflex Drug Wins New Label, Stock Jumps

    IBD
  36. Auxilium Presented New Analyses of XIAFLEX Peyronie's Disease Data at SMSNA ...

    Benzinga
  37. Auxilium Announces Results Of The XIAFLEX In Dupuytren's MULTICORD Contracture ...

    Benzinga
  38. UPDATE: Auxilium Posts Upbeat Q3 Profit

    Benzinga
  39. Vivus, Auxilium up on deal

    IBD
  40. Vivus, Auxilium Gain On Impotence Drug Deal

    IBD
  41. Auxilium Pharmaceuticals Announces License Agreement with Vivus for Marketing ...

    Benzinga
  42. Auxilium Raises Additional $50M

    Benzinga
  43. RBC Sees 10-15% Upside In Auxilium Shares On FDA Okay Of Xiaflex, 20% Downside ...

    Benzinga
  44. Auxilium Pharmaceuticals Announces Issuance of $350.0M of 1.50% Convertible ...

    Benzinga
  45. Cowen and Company Reiterates Outperform Rating on Auxilium Pharmaceuticals

    Benzinga
  46. Auxilium Pharmaceuticals and Xstelos Holdings Receive Certification Notice ...

    Benzinga
  47. US FDA Accepts XIAFLEX Supplemental Biologics License Application Filing ...

    Benzinga
  48. Auxilium Pharmaceuticals Submits Supplemental Biologics License Application ...

    Benzinga
  49. Auxilium, Pfizer to Conclude Agreement on XIAPEX EU Collaboration

    Benzinga
  50. Benzinga's M&A Chatter for Monday October 22, 2012

    Benzinga
Trading Center